WuXi AppTec (OTCMKTS:WUXAY) Shares Up 7.8% – Still a Buy?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) were up 7.8% during trading on Tuesday . The company traded as high as $25.3350 and last traded at $25.3350. 1,500 shares were traded during trading, a decline of 31% from the average session volume of 2,181 shares. The stock had previously closed at $23.51.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

WuXi AppTec Stock Performance

The stock’s 50-day moving average is $23.06 and its 200 day moving average is $18.49.

WuXi AppTec Company Profile

WuXi AppTec is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.

The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.

Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets.